Compliance and Sterility: GMP Standards for Primary and Secondary Packaging

A tray designed to hold vials upright and separated during storage, shipping, or clinical handling.

What is a vial tray?

The term "vial tray" refers to rigid or semi-rigid carriers—made from polymers, metals, or coated materials—designed to hold multiple vials securely during processing, sterilization, storage, and transport. Vial trays preserve vial orientation, protect vial shoulders and stoppers from mechanical damage, and facilitate automated handling in filling, inspection, and packaging equipment.

Primary vs. secondary packaging: how vial trays are classified

Whether a vial tray is considered primary or secondary packaging depends on contact with critical vial surfaces. Primary packaging directly contacts the sterile product or surfaces that are part of the product’s sterile barrier (for example, vial necks, stoppers, or inner surfaces). If a tray contacts those critical areas (e.g., touching the vial mouth or stopper in a way that could affect sterility or leachables), it must be managed under primary packaging controls. If it only supports or groups already-closed vials without contacting sterile interfaces, it is typically treated as secondary or tertiary packaging. This distinction drives the level of control, testing, and documentation required under GMP.

Regulatory framework and key standards

ISO 15378 (Primary packaging materials for medicinal products) requires a quality management system and GMP-compliant controls for materials that form the first barrier to the medicinal product. ISO 15378 emphasizes design control, supplier qualification, traceability, and documentation for material batches supplied for medicinal use.

EU GMP Annex 1 (Manufacture of sterile medicinal products) sets expectations for sterile manufacture and emphasizes contamination control strategies, environmental monitoring, and the management of items supplied as "ready-to-use" (RTU). Annex 1 requires that RTU items be supplied in a validated sterile state with appropriate labeling, certificates, and controls to ensure they do not compromise product sterility.

Ready-to-use (RTU) trays and supplier obligations

An RTU vial tray is supplied sterile and is intended for immediate use in a sterile environment without further cleaning or sterilization. Suppliers of RTU trays must provide validated sterilization methods, routine sterility assurance, Certificates of Analysis (CoA), and manufacturing batch records. For the customer, acceptance of RTU items requires documented qualification of the supplier, review of sterile process validation, and an incoming inspection and release procedure that aligns with the facility’s contamination control strategy.

Low-leachable materials and extractables & leachables (E&L)

Materials used in vial trays must be selected and qualified to minimize extractables and leachables that could migrate to vial surfaces and compromise product quality. Polymer choices commonly include medical- or pharmaceutical-grade cyclic olefin polymers (COP/COC), PTFE, or coated stainless steels, all chosen for low extractables and compatibility with sterilization methods (gamma irradiation, ethylene oxide, autoclaving). E&L risk should be assessed using industry guidance such as USP <1663> and <1664> (assessment and characterization of extractables and leachables). Where trays contact critical surfaces, manufacturers should provide E&L studies and material safety data demonstrating acceptable levels and toxicological risk assessments.

Traceability, documentation, and labelling

Traceability is essential across the supply chain. Best practice includes unique batch or lot identifiers on tray packaging, 2D barcodes or RFID tags, and accessible Certificates of Conformity, sterility certificates, and material declarations. Records should permit full traceability from tray production through sterilization, distribution, and use. Change control, supplier audits, and material specification documents must be retained to support investigations and recalls if required.

Maintaining hygiene and contamination control

Vial trays used in sterile operations should be handled within the facility’s contamination control strategy. For non-RTU trays, validated cleaning and sterilization processes must be in place before introduction to aseptic areas. For RTU trays, maintain clean chain-of-custody and aseptic transfer procedures: sealed packaging until point-of-use, controlled transfer into classified environments, and operators following gowning and handling SOPs. Environmental monitoring and personnel training are crucial to prevent bioburden or particulate contamination.

Validation and qualification

Key qualifications include supplier qualification, material characterization, sterilization validation (e.g., SAL 10^-6 for terminally sterilized RTU trays where appropriate), compatibility testing with cleaning agents and sterilization modalities, and E&L testing if trays contact critical surfaces. Packaging and transport validation should demonstrate that trays maintain sterility and functionality throughout expected storage and shipping conditions.

Implementation checklist (practical steps)

• Define whether trays are primary or secondary packaging based on contact with critical surfaces.
• Develop material specifications emphasizing low-leachables and sterilization compatibility.
• Qualify suppliers: audits, CoAs, sterility/validation dossiers, and E&L reports.
• Specify RTU requirements if trays are to be supplied sterile, and require sterilization validation and routine sterility testing.
• Establish incoming inspection, quarantine, and release procedures with full traceability.
• Validate cleaning and sterilization processes for reusable trays; validate transport and packaging for RTU trays.
• Include trays in environmental monitoring plans when used in aseptic areas and ensure staff training on handling and transfer.

Common mistakes to avoid

• Assuming a tray is "just secondary" without assessing contact risk—this can lead to inadequate controls where trays touch critical vial surfaces.
• Failing to require or review E&L data from suppliers when trays contact materials that could influence product safety.
• Relying on supplier sterility claims without supplier qualification, sterility validation, and batch documentation.
• Neglecting compatibility testing between tray materials and sterilization or cleaning processes, causing deformation, increased extractables, or microbiological risks.
• Poor traceability: missing lot numbers, unlabeled pallets, or lack of electronic records that hamper recalls or investigations.

Real-world example

A sterile filling facility shifted to RTU COP trays supplied with gamma sterilization. Before acceptance, the facility performed supplier qualification, reviewed sterilization validation and CoAs, requested E&L reports demonstrating negligible extractables after gamma exposure, and added tray lot IDs to their electronic batch records. The trays were transferred into the classified area in sealed overpouches and opened at point-of-use under laminar flow following SOPs. These controls reduced handling steps, decreased contamination risk, and maintained regulatory compliance under ISO 15378 and Annex 1 expectations.

Summary

Vial trays play an important role in sterile drug manufacture and distribution. Determining whether a tray is primary or secondary guides the regulatory and quality controls required. Compliance with ISO 15378 and EU GMP Annex 1, careful selection of low-leachable materials, validated sterilization (for RTU trays), stringent traceability, and rigorous hygiene and handling procedures are all essential to ensure that vial trays do not compromise product sterility, quality, or patient safety.